| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.045 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |